Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
Ivan Pourmir, Johanna Noel, Audrey Simonaggio, Stéphane Oudard, Yann Vano
Topics & Concepts
MedicineRenal cell carcinomaOncologyTyrosine kinaseKidney cancerInternal medicineClear cell renal cell carcinomaNivolumabCTLA-4BiomarkerImmune checkpointNephrologyTyrosine-kinase inhibitorCabozantinibCancer researchImmunotherapyImmune systemBioinformaticsCancerImmunologyT cellReceptorBiologyChemistryBiochemistryRenal cell carcinoma treatmentRenal and related cancersFerroptosis and cancer prognosis